Initiates Coverage on Milestone Scientific (NYSE:MLSS) started coverage on shares of Milestone Scientific (NYSE:MLSSGet Rating) in a report issued on Tuesday. The firm set a “sell” rating on the stock.

MLSS stock opened at $1.14 on Tuesday. Milestone Scientific has a twelve month low of $1.07 and a twelve month high of $3.17. The firm has a market capitalization of $77.66 million, a P/E ratio of -11.40 and a beta of 1.27. The business’s 50-day moving average price is $1.32.

About Milestone Scientific (Get Rating)

Milestone Scientific Inc designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic.

Further Reading

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with's FREE daily email newsletter.